In the wake the recent fungal meningitis outbreak, FDA has published a list of health care providers that have purchased drugs from the New England Compounding Center (NECC) since May 21, when the first lot of steroid injections linked to the fungal meningitis outbreaks was produced. The release identified customers in more than 40 states, and was accompanied by a separate list of products sold by NECC. For more information, or to view a list of the customers and products sold, click here.